BALAXI - Balaxi Pharmaceuticals

Balaxi Pharmaceuticals

BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth

1.9%

0.2%

9.7%

17.7%

24.5%

7.9%

41.4%

all

47.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 90 1.9%

86.9

127

Company Overview

Sales

241 Cr

Growth: -18.0%

Profit after Tax

37.1 Cr

Growth: -444.4%

Small Cap

497 Cr

P/E: 10.3x

Industry P/E: 26.4x

Fundamentals

Sales (Cr)	₹ 241
Growth	-18.0%
EBITDA	19.9%
P/S	2.0x
Dividend	0.0%
P/E	10.3x
Book Value	₹ 28.2
PEG Ratio	-0.6x
ROE	26.0%
P/B	3.1x

Shareholding Pattern

Institutions

Elara India Opportunities Fund Limited

9.5 %

Marshal Global Capital Fund Ltd

9.5 %

Amol Anand Mantri

1.73 %

Iepf

0.75 %

Promoters

Balaxi Overseas Private Limited

70.0 %

Ashish Maheshwari

1.81 %

Minoshi Maheshwari

1.06 %

Others

Increase Decrease No change

Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.

Investors (12)

iepf

elara.in...

p.p.zibi

Followers (1)

gmuralik